
New Chemotherapy for Childhood Acute Lymphoblastic Leukemia Patients
The FDA approval of calaspargase pegol-mknl provides a longer-acting chemotherapy option for certain patients with acute lymphoblastic leukemia. The...
The FDA approval of calaspargase pegol-mknl provides a longer-acting chemotherapy option for certain patients with acute lymphoblastic leukemia. The...
The U.S. Food and Drug Administration has approved the first of a new type of immunotherapy called CAR T-cell...